Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Sagent Pharmaceuticals, Inc. (SGNT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/01/2016 |
4
| Vivo Ventures V, LLC (10% Owner) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 09/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/31/2016 |
4
| OBERMAN ALLAN (CEO) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| Krizman Anthony (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| BULLOCK DONALD R (Executive V.P. Sales) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| Behrens Mary Taylor (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 7,097 shares
@ $21.75, valued at
$154.4k
Disposed/sold 8,556 restricted stock units
@ $21.75, valued at
$186.1k
Disposed/sold 691 restricted stock units
@ $21.75, valued at
$15k
Disposed/sold 1,381 restricted stock units
@ $21.75, valued at
$30k
Disposed/sold 1,860 restricted stock units
@ $21.75, valued at
$40.5k
Disposed/sold 760 restricted stock units
@ $21.75, valued at
$16.5k
Disposed/sold 6,379 options to buy
@ $11.6, valued at
$74k
|
|
| 08/31/2016 |
4
| FLANAGAN ROBERT J (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Gifted 4,150 shares
@ $0
Unknown transaction of 8,050 shares
@ $21.75, valued at
$175.1k
Unknown transaction of 2,000 shares
@ $21.75, valued at
$43.5k
Unknown transaction of 433,770 shares
@ $21.75, valued at
$9.4M
Disposed/sold 8,556 restricted stock units
@ $21.75, valued at
$186.1k
Disposed/sold 691 restricted stock units
@ $21.75, valued at
$15k
Disposed/sold 1,381 restricted stock units
@ $21.75, valued at
$30k
Disposed/sold 1,860 restricted stock units
@ $21.75, valued at
$40.5k
Disposed/sold 760 restricted stock units
@ $21.75, valued at
$16.5k
Disposed/sold 5,103 options to buy
@ $11.6, valued at
$59.2k
|
|
| 08/31/2016 |
4
| BRYNJELSEN SEAN (EVP, Business Development) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| WARD MICHAEL V. (Chief Legal Off. and Secretary) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| FEKETE MICHAEL (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| Harmon J Frank (EVP, Global Operations) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 8,915 shares
@ $21.75, valued at
$193.9k
Disposed/sold 18,897 options to buy
@ $13.46, valued at
$254.4k
|
|
| 08/31/2016 |
4
| Greve Jeffrey W. (Vice President, Controller) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 08/05/2016 |
4
| OBERMAN ALLAN (CEO) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 07/13/2016 |
4
| FEKETE MICHAEL (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Exercised 591 restricted stock units
@ $0 |
|
| 06/28/2016 |
4
| BULLOCK DONALD R (Executive V.P. Sales) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Granted 4,993 shares
@ $0
Granted 10,608 options to buy
@ $15.02, valued at
$159.3k
|
|
| 06/27/2016 |
3
| BULLOCK DONALD R (Executive V.P. Sales) has filed a Form 3 on Sagent Pharmaceuticals, Inc. |
| 05/04/2016 |
3
| WARD MICHAEL V. (Chief Legal Off. and Secretary) has filed a Form 3 on Sagent Pharmaceuticals, Inc. |
| 04/25/2016 |
4
| Vivo Ventures VI, LLC (10% Owner) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Sold 2,299 shares
@ $13.55, valued at
$31.2k
Sold 17 shares
@ $13.55, valued at
$230.4 |
|
| 04/25/2016 |
4
| Vivo Ventures V, LLC (10% Owner) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Sold 1,982 shares
@ $13.55, valued at
$26.9k
Sold 23 shares
@ $13.55, valued at
$311.7 |
|
| 04/18/2016 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Exercised 742 restricted stock units
@ $0 |
|
| 04/06/2016 |
3
| BRYNJELSEN SEAN (EVP, Business Development) has filed a Form 3 on Sagent Pharmaceuticals, Inc. |
| 04/06/2016 |
4
| BRYNJELSEN SEAN (EVP, Business Development) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Granted 9,844 shares
@ $0
Granted 21,016 options to buy
@ $12.19, valued at
$256.2k
|
|
| 03/22/2016 |
4
| Patterson Albert (EVP, Nat. Accts and Corp. Dev.) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 66 shares
@ $12.39, valued at
$817.7 |
|
| 03/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2016 |
3
| Harmon J Frank (EVP, Global Operations) has filed a Form 3 on Sagent Pharmaceuticals, Inc. |
| 10/07/2013 |
4
| MORGAN STANLEY INVESTMENT MANAGEMENT INC (10% Owner) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Sold 47,826 shares
@ $20.2667, valued at
$969.3k
|
|
| 10/03/2013 |
4
| MORGAN STANLEY INVESTMENT MANAGEMENT INC (10% Owner) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Sold 50,000 shares
@ $20.7006, valued at
$1M
Sold 40,020 shares
@ $20.3178, valued at
$813.1k
|
|
| 10/01/2013 |
4
| MORGAN STANLEY INVESTMENT MANAGEMENT INC (10% Owner) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Sold 31,300 shares
@ $20.5172, valued at
$642.2k
Sold 10,000 shares
@ $20.6, valued at
$206k
Sold 28,872 shares
@ $20.4637, valued at
$590.8k
Sold 25,000 shares
@ $20.3846, valued at
$509.6k
|
|
| 08/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/15/2013 |
4
| FEKETE MICHAEL (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 07/15/2013 |
3
| FEKETE MICHAEL (Director) has filed a Form 3 on Sagent Pharmaceuticals, Inc. |
| 02/25/2013 |
4
| FLANAGAN ROBERT J (Director) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Granted 3,039 restricted stock units
@ $0
Exercised 567 restricted stock units
@ $0 |
|
|
|
|